Exact Mass: 511.2503
Exact Mass Matches: 511.2503
Found 271 metabolites which its exact mass value is equals to given mass value 511.2503
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
His Ala Arg Glu
Ala Glu His Arg
Ala Glu Arg His
Ala Phe Phe Gln
Ala Phe Gln Phe
Ala His Glu Arg
Ala His Arg Glu
Ala His Val Trp
Ala His Trp Val
Ala Lys Met Tyr
Ala Lys Tyr Met
Ala Met Lys Tyr
Ala Met Tyr Lys
Ala Gln Phe Phe
Ala Arg Glu His
Ala Arg His Glu
Ala Val His Trp
Ala Val Trp His
Ala Trp His Val
Ala Trp Val His
Ala Tyr Lys Met
Ala Tyr Met Lys
Cys Lys Val Tyr
Cys Lys Tyr Val
Cys Val Lys Tyr
Cys Val Tyr Lys
Cys Tyr Lys Val
Cys Tyr Val Lys
Glu Ala His Arg
Glu Ala Arg His
Glu His Ala Arg
Glu His Arg Ala
Glu Arg Ala His
Glu Arg His Ala
Phe Ala Phe Gln
Phe Ala Gln Phe
Phe Phe Ala Gln
Phe Phe Gln Ala
Phe Lys Met Ser
Phe Lys Ser Met
Phe Met Lys Ser
Phe Met Ser Lys
Phe Gln Ala Phe
Phe Gln Phe Ala
Phe Ser Lys Met
Phe Ser Met Lys
Gly His Ile Trp
Gly His Leu Trp
Gly His Trp Ile
Gly His Trp Leu
Gly Ile His Trp
Gly Ile Trp His
Gly Leu His Trp
Gly Leu Trp His
Gly Trp His Ile
Gly Trp His Leu
Gly Trp Ile His
Gly Trp Leu His
His Ala Glu Arg
His Ala Val Trp
His Ala Trp Val
His Glu Ala Arg
His Glu Arg Ala
His Gly Ile Trp
His Gly Leu Trp
His Gly Trp Ile
His Gly Trp Leu
His Ile Gly Trp
His Ile Trp Gly
His Lys Met Pro
His Lys Asn Asn
His Lys Pro Met
His Leu Gly Trp
His Leu Trp Gly
His Met Lys Pro
His Met Pro Lys
His Asn Lys Asn
His Asn Asn Lys
His Pro Lys Met
His Pro Met Lys
His Arg Ala Glu
His Arg Glu Ala
His Val Ala Trp
His Val Trp Ala
His Trp Ala Val
His Trp Gly Ile
His Trp Gly Leu
His Trp Ile Gly
His Trp Leu Gly
His Trp Val Ala
Ile Gly His Trp
Ile Gly Trp His
Ile His Gly Trp
Ile His Trp Gly
Ile Trp Gly His
Ile Trp His Gly
Lys Ala Met Tyr
Lys Ala Tyr Met
Lys Cys Val Tyr
Lys Cys Tyr Val
Lys Phe Met Ser
Lys Phe Ser Met
Lys His Met Pro
Lys His Asn Asn
Lys His Pro Met
Lys Met Ala Tyr
Lys Met Phe Ser
Lys Met His Pro
Lys Met Pro His
Lys Met Ser Phe
Lys Met Tyr Ala
Lys Asn His Asn
Lys Asn Asn His
Lys Pro His Met
Lys Pro Met His
Lys Ser Phe Met
Lys Ser Met Phe
Lys Val Cys Tyr
Lys Val Tyr Cys
Lys Tyr Ala Met
Lys Tyr Cys Val
Lys Tyr Met Ala
Lys Tyr Val Cys
Leu Gly His Trp
Leu Gly Trp His
Leu His Gly Trp
Leu His Trp Gly
Leu Trp Gly His
Leu Trp His Gly
Met Ala Lys Tyr
Met Ala Tyr Lys
Met Phe Lys Ser
Met Phe Ser Lys
Met His Lys Pro
Met His Pro Lys
Met Lys Ala Tyr
Met Lys Phe Ser
Met Lys His Pro
Met Lys Pro His
Met Lys Ser Phe
Met Lys Tyr Ala
Met Pro His Lys
Met Pro Lys His
Met Ser Phe Lys
Met Ser Lys Phe
Met Tyr Ala Lys
Met Tyr Lys Ala
Asn His Lys Asn
Asn His Asn Lys
Asn Lys His Asn
Asn Lys Asn His
Asn Asn His Lys
Asn Asn Lys His
Pro His Lys Met
Pro His Met Lys
Pro Lys His Met
Pro Lys Met His
Pro Met His Lys
Pro Met Lys His
Gln Ala Phe Phe
Gln Phe Ala Phe
Gln Phe Phe Ala
Arg Ala Glu His
Arg Ala His Glu
Arg Glu Ala His
Arg Glu His Ala
Arg His Ala Glu
Arg His Glu Ala
Ser Phe Lys Met
Ser Phe Met Lys
Ser Lys Phe Met
Ser Lys Met Phe
Ser Met Phe Lys
Ser Met Lys Phe
Val Ala His Trp
Val Ala Trp His
Val Cys Lys Tyr
Val Cys Tyr Lys
Val His Ala Trp
Val His Trp Ala
Val Lys Cys Tyr
Val Lys Tyr Cys
Val Trp Ala His
Val Trp His Ala
Val Tyr Cys Lys
Val Tyr Lys Cys
Trp Ala His Val
Trp Ala Val His
Trp Gly His Ile
Trp Gly His Leu
Trp Gly Ile His
Trp Gly Leu His
Trp His Ala Val
Trp His Gly Ile
Trp His Gly Leu
Trp His Ile Gly
Trp His Leu Gly
Trp His Val Ala
Trp Ile Gly His
Trp Ile His Gly
Trp Leu Gly His
Trp Leu His Gly
Trp Val Ala His
Trp Val His Ala
Tyr Ala Lys Met
Tyr Ala Met Lys
Tyr Cys Lys Val
Tyr Cys Val Lys
Tyr Lys Ala Met
Tyr Lys Cys Val
Tyr Lys Met Ala
Tyr Lys Val Cys
Tyr Met Ala Lys
Tyr Met Lys Ala
Tyr Val Cys Lys
Tyr Val Lys Cys
(1S)-2-oxobornane-10-sulphonic acid, compound with 7-[2-(diethylamino)ethyl]-3,7-dihydro-1,3-dimethyl-1H-purine-2,6-dione (1:1)
1,3,5-Triazine, 2,4-diphenyl-6-[3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)[1,1-biphenyl]-3-yl]-
[(2R,3S,4S,5R,6S)-4-amino-6-[(1S,2S,3R,4S,6R)-4,6-diamino-3-[(2S,3R,5S,6R)-3-amino-5-hydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2-hydroxycyclohexyl]oxy-3,5-dihydroxyoxan-2-yl]methyl carbamate
6-[(2R,5R)-3-hydroxy-5-[4-[[(2R)-2-hydroxy-2-(4-hydroxyphenyl)ethyl]amino]-4-oxobutanoyl]oxy-6-methyloxan-2-yl]oxyheptanoic acid
(2R)-2-[(4R,5R)-5-[[cyclopentylmethyl(methyl)amino]methyl]-4-methyl-1,1-dioxo-8-[2-(3-pyridinyl)ethynyl]-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-2-yl]-1-propanol
N-[(4R,7R,8R)-5-[(2-fluorophenyl)-oxomethyl]-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]cyclopropanecarboxamide
N-[(4S,7S,8R)-5-[(2-fluorophenyl)-oxomethyl]-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]cyclopropanecarboxamide
N-[(4R,7R,8S)-5-[(2-fluorophenyl)-oxomethyl]-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]cyclopropanecarboxamide
N-[(4R,7S,8R)-5-[(2-fluorophenyl)-oxomethyl]-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]cyclopropanecarboxamide
N-[(4S,7R,8S)-5-[(2-fluorophenyl)-oxomethyl]-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]cyclopropanecarboxamide
(2S)-2-[(4R,5R)-5-[[cyclopentylmethyl(methyl)amino]methyl]-4-methyl-1,1-dioxo-8-[2-(3-pyridinyl)ethynyl]-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-2-yl]-1-propanol
N-[(4R,7S,8S)-5-[(2-fluorophenyl)-oxomethyl]-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]cyclopropanecarboxamide
N-[(4S,7R,8R)-5-[(2-fluorophenyl)-oxomethyl]-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]cyclopropanecarboxamide
N-[(4S,7S,8S)-5-[(2-fluorophenyl)-oxomethyl]-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]cyclopropanecarboxamide
(3R)-2-[(R)-tert-butylsulfinyl]-4-[3-(1-cyclopentenyl)phenyl]-3-(2-hydroxyethyl)-N-(2-methoxyethyl)-1,3-dihydropyrrolo[3,4-c]pyridine-6-carboxamide
(3S)-2-[(S)-tert-butylsulfinyl]-4-[3-(1-cyclopentenyl)phenyl]-3-(2-hydroxyethyl)-N-(2-methoxyethyl)-1,3-dihydropyrrolo[3,4-c]pyridine-6-carboxamide
2-Amino-3-[2,3-di(octanoyloxy)propoxy-hydroxyphosphoryl]oxypropanoic acid
2-Amino-3-[(3-heptanoyloxy-2-nonanoyloxypropoxy)-hydroxyphosphoryl]oxypropanoic acid
2-Amino-3-[(3-butanoyloxy-2-dodecanoyloxypropoxy)-hydroxyphosphoryl]oxypropanoic acid
2-Amino-3-[(2-decanoyloxy-3-hexanoyloxypropoxy)-hydroxyphosphoryl]oxypropanoic acid
2-Amino-3-[hydroxy-(3-propanoyloxy-2-tridecanoyloxypropoxy)phosphoryl]oxypropanoic acid
2-Amino-3-[hydroxy-(3-pentanoyloxy-2-undecanoyloxypropoxy)phosphoryl]oxypropanoic acid
3-[(3-Acetyloxy-2-tetradecanoyloxypropoxy)-hydroxyphosphoryl]oxy-2-aminopropanoic acid
1,2-dioctanoyl-sn-glycero-3-phosphoserine
A 3-sn-phosphatidyl-L-serine in which the two phosphatidyl acyl groups are specified as octanoyl.
Upidosin
Upidosin (Rec 15/2739) is an α-1 adrenoceptor (α-1 AR) antagonist. Upidosin shows moderate selectivity for the α-1A AR subtype. Upidosin shows uroselectivity in urethra and prostate with a Kb value of 2-3 nM higher than in ear artery and aorta with a Kb value of 20-100 nM. Upidosin inhibits [3H]prazosin binding to cloned human α-1A adrenergic receptor. Upidosin can be used for the research of urethral obstruction[1].